Novatek Pharmaceuticals
Manufacturing · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3569 Business Center Dr Ste 110, Pearlan...Phone Number
(877) 662-8351Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Novatek Pharmaceuticals
Novatek Pharmaceuticals specializes in the development of NP-101, a naturally derived immunotherapy from Nigella Sativa, aimed at treating cancers and infectious diseases. The company focuses on enhancing T-cell responses and boosting the immune system while minimizing adverse effects associated with traditional therapies. With a team boasting over 100 years of clinical research experience, Novatek has a strong pharmaceutical pipeline and has conducted significant clinical trials demonstrating the efficacy of NP-101. Their primary clients include patients suffering from various cancers and infectious diseases, as well as healthcare providers seeking innovative treatment options.Explore more
Novatek Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Novatek Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Novatek Pharmaceuticals
Check if Novatek Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Novatek Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Novatek Pharmaceuticals launches new products
Check out if Novatek Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Novatek Pharmaceuticals has new funding data
Earning: See what the market has to say on Novatek Pharmaceuticals recently announced quarterly report
Novatek Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Novatek Pharmaceuticals
Find more new buyers
Compare Similar Companies to Novatek Pharmaceuticals
Compare insights from companies similar to Novatek Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Novatek Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Novatek Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Novatek Pharmaceuticals.
Novatek Pharmaceuticals Tech Stack
A closer look at the technologies used by Novatek Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Novatek Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Novatek Pharmaceuticals specializes in the development of NP-101, a naturally derived immunotherapy from Nigella Sativa, aimed at treating cancers and infectious diseases. The company focuses on enhancing T-cell responses and boosting the immune system while minimizing adverse effects associated with traditional therapies. With a team boasting over... Read More
